Lv1
70 积分 2024-08-06 加入
Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NYM005 and initial experience in clear cell renal cell carcinoma: an interim analysis of a prospective trial
8天前
已完结
Exploration of radionuclide labeling of a novel scFv-Fc fusion protein targeting CLDN18.2 for tumor diagnosis and treatment
13天前
已完结
Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside
13天前
已完结
The old CEACAMs find their new role in tumor immunotherapy
13天前
已完结
Identification of a CEACAM5 targeted nanobody for positron emission tomography imaging and near-infrared fluorescence imaging of colorectal cancer
14天前
已完结
Radiolabeled peptides and their expanding role in clinical imaging and targeted cancer therapy
14天前
已完结
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer
14天前
已完结
Small molecule and peptide CXCR4 antagonists. A patent review from 2019 to 2024
14天前
已完结
Clinical comprehensive evaluation of [18F]AlF-FAP-NUR PET: multi-time-point imaging, head-to-head comparison with [18F]FDG
22天前
已完结
Development of [225Ac]Ac‑LNC1011 for targeted alpha-radionuclide therapy of prostate cancer
28天前
已完结
皖公网安备34019202002308
